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Abstract
Purpose The recently introduced Cancer Communication As-
sessment Tool (CCAT-PF) measures congruence in patient–
caregiver communication and was initially validated in lung
cancer patients. Contributing to a greater proportion of the
variance in the conflict scores, primary caregivers were hy-
pothesized to experience greater stress. For a detailed under-
standing of conflicting communication patterns of cancer-
affected families, our study aimed for psychometric validation
of the CCAT-PF in a sample covering heterogeneous tumor
entities.
Methods Subsequent to a cross-sectional survey of 189 pairs
of cancer patients (31 % gastrointestinal, 34 % lung, and 35%
urological) and their caregivers’ exploratory factor analysis
with principal component condensation and varimax rotation
was conducted (response rate, 74.2 %). Reliability and con-
struct validity were assessed calculating Cronbach’s α and
Pearson correlation coefficients for CCAT-P and CCAT-F
scales and related constructs, respectively.
Results Cancer-related communication according to the
CCAT-PF can be subdivided into four factors including the
scalesDisclosure, Limitation of treatment, Family involvement
in treatment decisions, and Continuing treatment. Reliability
ranged from α=.51–.68. The Disclosure scale, describing
poor cancer-related communication of the patient, was corre-
lated with patient’s distress (QSC-R10: r=.30, p<.0001),
unmet needs in several areas (SCNS-SF-34: r=.25–.32,
p<.001), and negatively with social/family well-being
(FACT: r=−0.31, p<.0001). Higher scores on the scale were
significantly associated with considerable decrements in emo-
tional well-being especially for caregivers perceiving patients’
disclosure as problematic.
Conclusions The Disclosure scale originating from the
CCAT-PF emerged as a short, valid, and reliable stand-alone
instrument for identifying conflicting communication in pa-
tient–caregiver–dyads at risk.
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Introduction
There is wide agreement that cancer may impact an entire
family causing “fears, uncertainty, disrupted life plans,
rearranged schedules and routines, changed interpersonal
communication, existential worries, alterations in household
members’ functioning, and heightened household tension” [1,
2]. For example, Burns and colleagues identified fluctuating
awareness of treatment goals among 163 cancer patients and
their principal family caregivers [3]. It was figured that dis-
crepancies in patient–caregiver–dyads might complicate the
delivery of effective care at the latest when patients are seri-
ously ill. However, valid and reliable instruments to assess
types and quality of conflict in communication to specify key
aspects for psychosocial interventions remain scarce. Recent-
ly, the Cancer Communication Assessment Tool for Patients
and Families (CCAT-PF) was introduced as a measure of
congruence in patient–family caregiver communication [4].
Construction was aimed at finding a clinical screening tool for
family discord in cancer. Validation was conducted with a
sample of 190 advanced stage non-small cell lung cancer
patients and their primary caregivers [5]. The final scale
comprised 18 items within eight domains, “a high sum total
of the 18-item absolute difference scores indicating disagree-
ment between patient and caregiver” [4]. Significantly, higher
CCAT-PF conflict scores were exhibited by younger care-
givers, adult children caregivers, and patients with lower
income. Different domains of disagreement did not correlate
with each other, underscoring the importance of separate
examination of domain scores in addition to the CCAT-PF
total score. As a greater proportion of the variance in the
conflict scores that was contributed by caregivers, it was
concluded that family caregivers are more aware of deviations
from an open dialogue. Caregivers may therefore be
experiencing greater stress. For a detailed understanding of
conflicting communication patterns of cancer-affected fami-
lies, our study aimed for German translation and psychometric
reassessment of the CCAT-PF in a sample covering heteroge-
neous tumor entities.
Methods
Study design and sample Initial sample size calculation indi-
cated that 134 subjects were necessary to test for sufficient
reliability (Cronbach’s α=.80) [6]. Psychometric validation
was conducted in a cross-sectional survey of 189 pairs of
patients with diverse malignancies (31 % gastrointestinal,
34 % lung, and 35 % urological) and their primary caregivers.
The patient sample was treated either as out- or inpatients at
the National Centre for Tumour Diseases and the affiliated
Thoraxklinik in Heidelberg. Caregivers, defined as nearest lay
care providers, were determined by patients themselves, as in
the initial study that developed the CCAT-PF. Data was col-
lected on July/August 2012. Sociodemographic data was pro-
vided by patients and medical data was obtained frommedical
records and the attending physician. The study was approved
by the Ethical Commission of Heidelberg Medical School
(Ethic Approval/Registration Number: S-287/2012).
Measurement The German version of the CCAT-PF was
based on a back translation by two independent translators.
As there is no nationwide hospice care established inGermany
and since most people are still unfamiliar with the idea [7], we
excluded item 18 (“I would feel uncomfortable if the doctor
began to talk to me about hospice care.”) from the German
version of the CCAT-PF. Furthermore, to assess construct
validity, the questionnaire set comprised instruments assessing
disease-related distress (Questionnaire on Distress in Cancer
Patients-Short Form, QSC-R10) [8], depression and anxiety
(Patient Health Questionnaire-4, PHQ-4) [9], and unmet needs
(Supportive Care Needs Survey, SCNS-SF34/SCNS-P&C-G)
for patients and caregivers [10]. Additionally, patients com-
pleted the Functional Assessment of Cancer Therapy (FACT-
G/FACT-L for lung cancer patients respectively) [11, 12],
while caregivers completed the Caregiver Strain Index (CSI)
[13].
Statistical analysis Only complete pairs of questionnaire sets
were included in the analyses. Four sets in which >40 % of
CCAT-P and/or CCAT-F items were missing were excluded
from the analysis. Descriptive statistics was computed for
sample characteristics and item analysis. Evaluation of scale
structure exploratory factor analysis with principal component
condensation and varimax rotation was conducted [14]. The
number of factors to be retained was determined according to
Kaiser–Guttman criteria and the scree plot criteria. Assess-
ment of reliability included estimation of internal consistency
(Cronbach’s α). Construct validity was investigated using
Pearson product–moment correlations. To identify differences
between subgroups, the Student’s t tests and analyses of
variance (ANOVA) were used. Non-responder analysis was
conducted to test for representativeness of the sample regard-
ing gender, age, and tumor type.
Results
Sociodemographic and medical data Three hundred thirty-
one patients were screened for eligibility, 64 of whom were
not eligible (no relative/caregiver present, n=20; insufficient
German language proficiency, n=8; too recently diagnosed,
n=5; poor general condition; assessed by attending physician,
n=2; patient subjectively too distressed, n=29). Most of the
patients who declared themselves as too distressed for
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participation were feeling too weak after high-dose chemo-
therapy treatment earlier on the same day. From the remaining
267 pairs, 44 declined participation and 25 did not return one
of the two questionnaire sets (response rate, 74.2 %). Subjects
refusing participation or not returning questionnaires did not
differ significantly with respect to age (p=.60) or gender
(p=.66) from those who did. However, lung cancer patients
were more likely to refuse participation than subjects with
urological or gastrointestinal tumors (p<.001). Enrolled pa-
tients were predominantly male (68 %), had a mean age of
63 years, and had a post-secondary education level (56 %).
The majority was suffering from late-stage (metastasized)
disease (75 %), had undergone chemotherapy in the last
2 months before the survey (78 %), and had a WHO-ECOG
performance status below 2 when assessed (91 %). Caregivers
were predominantly female (73 %) and most commonly
spouses (84 %), followed by adult children (12 %). Mean
age of caregivers was 58 years with 57 % of them having a
post-secondary education level.
Item analysis and evaluation of the scale structure Extreme
skew distribution (g=2.86 for the CCAT-P and 2.98 for
Table 1 Scale and item characteristics for CCAT-P and CCAT-F questionnaires
CCAT-P CCAT-F
Scale 1 Disclosure
Cronbach’s α=.66
Factor loading Mean SD Mean SD
Explained variance, 21.04 % – 2.00 .87 1.96 .86
2 I hesitate to mention treatment side effects to my doctors or nurses. .53 1.84 1.27 1.98 1.32
13 My family does not really listen when I talk about my cancer. .51 1.57 1.25 1.42 0.98
14 I avoid talking about cancer to my family because I don’t want to upset them. .74 2.08 1.37 1.83 1.22
15 I don’t tell my family about my problems because there is nothing they can do to help. .74 1.95 1.29 2.17 1.40
16 I am frustrated when my family is overprotective of me because of my cancer. .66 2.56 1.47 2.40 1.47
Scale 2 Limitation of treatment
Cronbach’s α=.51
Factor loading Mean SD Mean SD
Explained variance, 12.52 % – 3.26 1.18 2.52 1.06
5 If treatment caused financial hardship for my family, I would not take it. .63 3.01 1.75 1.53 1.11
7 If treatment made me sick every day, I would not take it. .79 2.82 1.57 2.85 1.54
8 I could see that there could come a point when taking treatment would not
be worth the discomfort it causes.
.46 3.96 1.72 3.22 1.79
Scale 3 Family involvement in treatment decisions
Cronbach’s α=.68
Factor loading Mean SD Mean SD
Explained variance, 12.06 % – 4.90 1.18 4.53 1.33
1 My family plays a big role in the decisions I make about my cancer treatment. .62 5.03 1.38 4.30 1.79
10 I value my family’s judgement about treatment decisions. .75 4.77 1.34 2.38 1.66
Scale 4 Continuing treatment
Cronbach’s α=.51
Factor loading Mean SD Mean SD
Explained variance, 11.04 % – 4.33 1.21 4.44 1.23
3 In general, side effects are not really important when I consider my larger
goals of treatment.
.59 4.05 1.49 3.85 1.61
4 Medical science may find a cure for cancer so I am willing to take any
treatment now to stay alive.
.67 4.59 1.45 5.00 1.42
Total explained variance, 56.66 %
Items without clear factor loading/excluded items Mean SD Mean SD
– – – –
6 My family and I have different views about the goal of treatment. 1.53 1.12 1.70 1.29
9 I am willing to take treatment that causes me a significant amount of pain
if I can live a few months longer.
2.83 1.67 2.35 1.49
11 My family’s acceptance of my treatment decisions depends on how much
they like my doctor(s).
2.24 1.56 2.38 1.66
12 It is important to base decisions about my cancer treatment on sources of
information other than my doctor.
2.48 1.56 2.92 1.64
17 My family blames my cancer on my not having taken better care of myself.
[excluded due to extreme skewness]
1.29 0.73 1.39 0.94
18 I would feel uncomfortable if the doctor began to talk to me about hospice
care. [excluded a priori]
– – – –
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the CCAT-F) of item 17 (“My family blames my can-
cer on my not having taken better care of myself.”) for
patient and caregiver ratings led to its exclusion from
further evaluation. First, CCAT-PF as patient/caregiver
discrepancy score was computed according to the orig-
inal scoring instructions (see Table 1) [4]. However,
correlation of CCAT-PF discrepancy score did not yield
any correlation with other theoretically related mea-
sures applied in the study. Assuming different
subdomains of familial cancer-related communication,
analysis continued with investigating the discrepancy
scores between CCAT-P and CCAT-F by factor analy-
sis. Scree plot and Kaiser–Guttman criteria suggested a
five-factor solution. However, the fifth factor, covering
items 13 and 14, was dropped due to low-content
validity and very poor reliability (α=.31). In addition,
items 15 and 16 were excluded, lacking distinct load-
ings on a factor. The final model led to four scales that
were named ‘Disclosure’, ‘Limitation of treatment,’
‘Family involvement in treatment decisions,’ and ‘Con-
tinuing treatment’ (see Table 1). These scales explained
56 % of the total variance with substantial factor loadings
>.45 throughout.
Assessment of reliability and validity Scales demonstrated
Cronbach’s alphas in the range α=.51—.68 (see Tables 1
and 2). Regarding construct validity, the Disclosure scale
(patient version), describing poor cancer-related communi-
cation of the patient, was correlated with patient’s distress
(QSC: r=.30; p<.0001), unmet needs in several areas
(SCNS-SF-34: r=.25–.32; p<.001), and negatively with
social/family well-being (FACT: r=−0.31; p<.0001). In
contrast, the latter was positively associated with Family
involvement in treatment decisions and Continuing treat-
ment. For caregivers, correlations for the Disclosure scale
(caregiver version) were more pronounced with regard to
anxiety (GAD-2: r=.32; p<.0001) and psychological
needs (SCNS-P&C-G: r=.35; p<.0001). A lack of open
communication from the caregiver’s perspective was also
associated with higher disease-related distress (QSC-R10:
r=.32; p<.0001) and strain (CSI: r=.29; p<.0001) on the
caregiver’s side.
Table 2 Pearson correlation coefficients for CCAT-P and CCAT-F scales and related constructs
Disclosure Limitation
of treatment
Family involvement
in treatment decisions
Continuing
treatment
Patient (CCAT-P)
SCNS—Psychological 0.29* 0.21 −0.10 −0.07
SCNS—Heath system and information 0.32** 0.09 −0.05 −0.11
SCNS—Physical and daily living 0.21 0.16 −0.06 −0.16
SCNS—Patient care and support 0.26* 0.03 −0.13 −0.15
SCNS—Sexuality 0.25* 0.17 −0.14 −0.14
PHQ−2 0.09 0.11 −0.07 −0.09
GAD−2 0.18 0.13 −0.04 −0.09
QSC−R10 0.30** 0.21 −0.18 −0.23
FACT—Physical well-being −0.12 −0.08 0.07 0.22
FACT—Social/Family well-being −0.31** −0.06 0.26* 0.27*
FACT—Emotional well-being −0.16 −0.20 0.13 0.14
FACT—Functional well-being −0.13 −0.11 0.12 0.29**
FACT—Total −0.13 −0.10 0.11 0.28**
Caregiver (CCAT-F)
SCNS-P&C—Psychological and emotional 0.35** 0.10 −0.21 −0.12
SCNS-P&C—Health care service 0.22 0.21 −0.21 −0.15
SCNS-P&C—Work and social needs 0.30** 0.20 −0.09 −0.09
SCNS-P&C—Communication and family 0.26* 0.11 −0.18 −0.09
PHQ-2 −0.01 −0.01 −0.05 −0.13
GAD-2 0.32** 0.10 −0.18 −0.15
QSC-R10 0.32** 0.13 −0.12 −0.18
CSI 0.29** 0.20 −0.07 −0.15
*p<.001; **p<.0001
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Subgroup analysis Subgroup analyses were conducted for
gender, age group, caregiver type, tumor site, and WHO-
ECOG performance status. Spouses of patients scored higher
on Continuing treatment than other family members (Δmean
[SD], 0.63 [1.22]; p<.05). Patients scored significantly higher
on Family involvement in treatment decisions if either they (Δ
mean [SD], 0.75 [1.13]; p<.0001) or their caregiver (Δ mean
[SD], 0.47 [1.16]; p<.01) were aged 60 years or older.
Discussion
This study aimed for a deeper insight in conflictual com-
munication patterns of cancer patients and their families.
We therefore undertook a psychometric reassessment of
the CCAT-PF using a German version with special regard
to evaluation of the scale structure. Whereas the original
score covers a wide range of content areas where families
might disagree, we aimed for higher content validity in
this study using subdomains of CCAT-PF separately. Con-
ceptualizing communication as a multidimensional con-
struct, our exploratory factor analysis revealed a four-
factor model with scales demonstrating sufficient internal
consistencies to allow for content-specific interpretation.
Higher social quality of life in the patient–caregiver–rela-
tionship went along with the wish to continue treatment
besides low chances and/or high side effects. In this case,
greater family involvement in decisions regarding treat-
ment was also observed. When considering disclosure, a
lack of dialogue was associated with higher distress and
consequently higher needs by both parties, but for the
caregiver, it also entailed a significantly higher degree of
anxiety and strain. We could not confirm a significant
association between communication and depression, as
previously reported [4]. Overall, the Disclosure scale orig-
inating from the CCAT-PF emerged as a short, valid, and
reliable tool to assess risks for impaired affective adjust-
ment in patients and caregivers dealing with cancer.
Higher scores on the scale as an indicator for low
cancer-related communication were significantly associated
with considerable decrements in emotional and social well-
being for caregivers; this association was more pronounced
in caregivers than for patients. This observation is in
accordance with the notion that caregivers especially might
be negatively affected when patients choose to withhold
communication [15–17]. In accordance with the original
work [4] emphasizing the necessity of separate examina-
tion of individual domain scores, in addition to the CCAT-
PF total score, we propose the Disclosure subscale as a
stand-alone instrument for identifying patient–caregiver–
dyads at risk. Tailoring psychosocial interventions to
improve open communication may help patients and their
caregivers better adjust to a cancer diagnosis [18].
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